NovAliX SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NovAliX SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10610
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NovAliX SAS (NovAliX) is a contract research organization that offers outsourcing and insourcing research services for drug discovery. The organization provides chemical biology services such as chemistry, biophysics, drug discovery and protein purification services. Its biophysics services include structural studies, ligand screening and interaction characterization. NovAliX’s chemistry services comprise process chemistry, discovery chemistry and custom synthesis. The organization also develops research and development technologies such as surface plasmon resonance, (SPR), x-ray crystallography, nuclear magnetic resonance spectroscopy, native mass spectrometry (native MS), and others. It serves research institutions, biotechnology and pharmaceutical companies. NovAliX is headquartered in Illkirch, France.

NovAliX SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovAliX SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NovAliX SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
NovAliX SAS, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
NovAliX Enters into Agreement with UCB Biopharma 10
Cantabio Pharma Enters into Drug Discovery Agreement with NovAliX 11
NovAliX Enters Into Agreement With Kyowa Hakko Kirin To Develop Drug Candidates 12
NovAliX Enters Into Agreement With Inventiva For Nuclear Receptor Drug Discovery 13
NovAlix Enters Into Drug Discovery Agreement With Kyowa Hakko Kirin 14
NovAliX And Servier Enter Into Drug Discovery Agreement with Les Laboratoires 15
NovAliX Enters Into Multi-Target Integrated Drug Discovery Collaboration With Teijin Pharma 16
NovAliX SAS – Key Competitors 17
NovAliX SAS – Key Employees 18
NovAliX SAS – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
NovAliX SAS, Pharmaceuticals & Healthcare, Key Facts 2
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovAliX SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovAliX SAS, Deals By Therapy Area, 2012 to YTD 2018 8
NovAliX SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
NovAliX Enters into Agreement with UCB Biopharma 10
Cantabio Pharma Enters into Drug Discovery Agreement with NovAliX 11
NovAliX Enters Into Agreement With Kyowa Hakko Kirin To Develop Drug Candidates 12
NovAliX Enters Into Agreement With Inventiva For Nuclear Receptor Drug Discovery 13
NovAlix Enters Into Drug Discovery Agreement With Kyowa Hakko Kirin 14
NovAliX And Servier Enter Into Drug Discovery Agreement with Les Laboratoires 15
NovAliX Enters Into Multi-Target Integrated Drug Discovery Collaboration With Teijin Pharma 16
NovAliX SAS, Key Competitors 17
NovAliX SAS, Key Employees 18
NovAliX SAS, Subsidiaries 19

List of Figures
NovAliX SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovAliX SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovAliX SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[NovAliX SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Matrix Service Co:企業の戦略・SWOT・財務分析
    Matrix Service Co - Strategy, SWOT and Corporate Finance Report Summary Matrix Service Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Gramercy Property Trust:企業のM&A・事業提携・投資動向
    Gramercy Property Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gramercy Property Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • AC Immune SA (ACIU):医療機器:M&Aディール及び事業提携情報
    Summary AC Immune SA (AC Immune) is a biopharmaceutical company that develops products for treating neurodegenerative diseases. It discovers, designs and develops innovative proprietary medicines to prevent, diagnose and treat neurodegenerative diseases associated with protein misfolding. The compan …
  • Eckert & Ziegler BEBIG SA (EZBG):企業の財務・戦略的SWOT分析
    Summary Eckert & Ziegler BEBIG SA (Eckert & Ziegler) a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG, is a medical device company that produces and distributes brachytherapy and radiotherapy products. The company offers products such as permanent prostate implants, HDR afterloaders, …
  • Alios BioPharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alios BioPharma Inc (Alios BioPharma), a subsidiary of Janssen Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops novel therapies for treatment of viral diseases. The company offers drugs for the treatment of viral infections such as respiratory syncytial virus, i …
  • MakeMyTrip Limited:企業の戦略・SWOT・財務分析
    MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report Summary MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Eisai Inc:企業の戦略的SWOT分析
    Eisai Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Riot Blockchain Inc (RIOT):医療機器:M&Aディール及び事業提携情報
    Summary Riot Blockchain Inc (Riot Blockchain) builds, operates and supports blockchain technologies. Its primary operations include mining of cryptocurrencies and development of exchange and mining pool platforms. The company focuses on both Bitcoin and Ethereum blockchain ecosystems. Riot Blockchai …
  • NMDC Ltd:企業の戦略・SWOT・財務情報
    NMDC Ltd - Strategy, SWOT and Corporate Finance Report Summary NMDC Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Biocon Ltd (BIOCON):企業の財務・戦略的SWOT分析
    Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Euronav NV (EURN):企業の財務・戦略的SWOT分析
    Summary Euronav NV (Euronav) is a transportation and logistics company that offers shipping services. The company provides seaborne transportation, tanker shipping, proactive management, fleet composition and ship management services. It offers ship management services which includes technical servi …
  • Acushnet Holdings Corp. (GOLF):企業の財務・戦略的SWOT分析
    Acushnet Holdings Corp. (GOLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Pacific Energy Ltd (PEA):企業の財務・戦略的SWOT分析
    Summary Pacific Energy Ltd (PEL) operates as a power generation company that develops, operates and maintains renewable energy power stations. The company operates Kalgoorlie Power Systems that operates site locations across Northern Territory, Western Australia and South Australia, among others. It …
  • China Mobile Limited:企業の戦略・SWOT・財務情報
    China Mobile Limited - Strategy, SWOT and Corporate Finance Report Summary China Mobile Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sejal Glass Limited (SEZAL):企業の財務・戦略的SWOT分析
    Sejal Glass Limited (SEZAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • China Eastern Airlines Corporation Limited:企業のM&A・事業提携・投資動向
    China Eastern Airlines Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Eastern Airlines Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Mega Uranium Ltd. (MGA):企業の財務・戦略的SWOT分析
    Mega Uranium Ltd. (MGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • True Diagnostics Inc:製品パイプライン分析
    Summary True Diagnostics Inc (True Diagnostics) is a research, development and manufacturing company that offers in-vitro immunodiagnostic test systems and reagents. The company provides trueDX platform technology including trueDX reader, trueDX software, trueDX-TSH test, trueDX-T4 test, trueDX-Gneg …
  • Omniox Inc-製薬・医療分野:企業M&A・提携分析
    Summary Omniox Inc (Omniox) is a biotechnology company that develops new medicines for hypoxic diseases. The company's H-NOX products are tailored for the treatment of hypoxic cancers, which include giloblastoma, metastatic brain cancer, head-and-neck cancer, pancreatic cancer, lung cancer, and pros …
  • JMC Projects (India) Ltd (JMCPROJECT):企業の財務・戦略的SWOT分析
    JMC Projects (India) Ltd (JMCPROJECT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆